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Background: An efficient method for the identification of medicinal plant products is now a priority as the global
demand increases. This study aims to develop a DNA-based method for the identification and authentication of
plant species that can be implemented in the industry to aid compliance with regulations, based upon the
economically important Hypericum perforatum L. (St John’s Wort or Guan ye Lian Qiao).
Methods: The ITS regions of several Hypericum species were analysed to identify the most divergent regions and
PCR primers were designed to anneal specifically to these regions in the different Hypericum species. Candidate
primers were selected such that the amplicon produced by each species-specific reaction differed in size. The use
of fluorescently labelled primers enabled these products to be resolved by capillary electrophoresis.
Results: Four closely related Hypericum species were detected simultaneously and independently in one reaction.
Each species could be identified individually and in any combination. The introduction of three more closely related
species to the test had no effect on the results. Highly processed commercial plant material was identified, despite
the potential complications of DNA degradation in such samples.
Conclusion: This technique can detect the presence of an expected plant material and adulterant materials in one
reaction. The method could be simply applied to other medicinal plants and their problem adulterants.Background
The quality of Chinese medicines (CM) has been ques-
tioned because of “continuing evidence of an inter-
national trade in herbal remedies made to an unreliable
standard” [1-3], and there is increasing international de-
mand for regulation of phytomedicines and definitive
quality standards [4,5]. In the European Union (EU), the
Traditional Herbal Medicines Directive (Directive 2004/
24/EC) regulates medicinal plant products for human
use, and all medicinal plant products must now hold a
Traditional Herbal Registration (THR) certified by a logo
on all packaging. To gain a THR, many factors must be
certified, such as the identification and authentication of
the medicinal plant material upstream of manufacturing
and processing. This is currently achieved by morpho-
logical and chemical methods, both of which are time-
consuming and cost-intensive [6].* Correspondence: ads@dmu.ac.uk
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reproduction in any medium, provided the orDNA-based methods are a preferred alternative, be-
cause they are more efficient, less expensive and time-
consuming, require less plant material, and can reliably
distinguish materials to the species level [6-9]. However,
the current identification methods (DNA-based and
chemical) are not capable of resolving mixtures of sev-
eral plant species simultaneously.
Identification of species independently and concur-
rently in complex mixtures has become increasingly im-
portant for regulators based on two main factors. First,
adulteration and contamination occur, particularly with
rare and expensive medicinal plant species that are sub-
stituted with less valuable alternatives [10,11]. These
alternatives may have no biological activity or might
have detrimental health implications. Therefore, the tar-
get plant and the dangerous adulterant must be identi-
fied to assess the safety of products. Second, synergistic
polyherbal formulations are fundamental to the practices
of CM, in that the use of specific combinations of medi-
cinal plant materials results in an enhanced outcome, i.e.
the whole being greater than the sum of its parts. Eachl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Voucher numbers and species for samples from
the DNA Databank of the Royal Botanic Gardens at Kew
Kew DNA Bank Voucher number Hypericum species Authority
13854 H. androsaemum L.
13866 H. kouytchense H.Lév.
13896 H. maculatum Crantz
13921 H. perforatum L.
13923 H. athoum Boiss.&Orph.
13929 H. calycinum L.
13993 H. ascyron L.
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such preparations.
As a pilot study for the design of industry-standard
DNA-based identification assays, Hypericum perforatum
L. (St John’s Wort or Guan ye Lian Qiao), which is used
for its anti-inflammatory and antimicrobial properties in
CM and for the treatment of mild to moderate depres-
sion in Europe [12], was selected as the target for the de-
sign of a new assay.
The nuclear ribosomal internal transcribed spacer
(nrITS) regions were used as targets for the design, and the
sequences from 15 Hypericum species were aligned and
analysed to identify the most divergent regions. PCR pri-
mers were then designed to anneal specifically to these
regions of the different species. Candidate primers were
selected such that the species-specific product of each PCR
differed in size and could be resolved by capillary electro-
phoresis with the fluorescently labelled primers.
This method is capable of detecting the closely related
species Hypericum androsaemum, Hypericum athoum,
Hypericum ascyron and Hypericum perforatum individu-
ally and in any combination, from within a mixture of
DNA from seven Hypericum species. This technique has
the power to both confirm the presence of the expected
plant material and detect the adulterant material in one
reaction. The method of design can be replicated for any
other medicinal plants and their problem adulterants.
This study aims to develop a DNA-based method for the
identification and authentication of plant species that can
be implemented in the industry to aid compliance with
regulations, through the discrimination of several different
Hypericum species, based on a similar design to that used
by Tobe and Linacre [13] for identifying mammalian spe-
cies. These species represent a worst-case scenario for dis-
crimination, as they are extremely closely related.
Methods
Primer design
Species-specific primers were designed using Allele ID
software (PremierBiosoft, USA) [14] available at http://
www.premierbiosoft.com/bacterial-identification/index.
html. The Hypericum nrITS sequences used for the de-
sign template were obtained from GenBank at http://
www.ncbi.nlm.nih.gov/, with accession numbers and
species as follows: AJ414728, Hypericum calycinum;
AY555839; Hypericum perforatum subsp. perforatum;
AY555842. Hypericum maculatum; AY555846, Hyperi-
cum athoum; AY555849, Hypericum ascyron; AY555853,
Hypericum kouytchense; and AY573012, Hypericum
androsaemum. Potential interactions between primers
were assessed using AutoDimer v.1 Software (National
Institute of Standards and Technology, USA) [15] avail-
able at http://yellow.nist.gov:8444/dnaAnalysis/primer-
ToolsPage.do.Initial PCR
The DNA samples used as templates for the initial primer
testing were supplied by the Royal Botanic Gardens at Kew
(UK) (Table 1). The nrITS1 region was amplified using pri-
mers ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′) and
ITS4 (5′-TCCTCCGCTTATTGATATGC-3′) [16]. The
PCRs were conducted with the GeneAmpW High Fidelity
PCR System (Applied Biosystems, USA), using a final vol-
ume of 50 μL. The PCRs in 0.2-mL polypropylene tubes
consisted of GeneAmp High Fidelity PCR Buffer (without
MgCl2) (1×), MgCl2 (2.5 mM), GeneAmp High Fidelity En-
zyme Mix (2.5 U), primers (0.1 μM each), dNTPs (0.1 μM
each), nuclease-free water and template DNA (0.7–1 μg).
A GeneAmp PCR System 9700 thermal cycler (Applied
Biosystems, USA) was used with the following programme:
initial denaturation step of 7 min at 95°C; 30 cycles of 1
min at 95°C, 30 s at 60°C and 1 min at 72°C; and final ex-
tension period of 7 min at 72°C.Primer validation
The initial testing of the species-specific primers was con-
ducted by conventional PCR using the High-Fidelity PCR
amplicons as DNA templates. The products from these
amplifications were diluted to a suitable working concen-
tration (H. athoum, 1 × 10-4 dilution; remainder, 1 × 10-5 di-
lution). This enabled all possible combinations to be tested
against vouchered DNA samples, which were in limited
supply. To test cross-amplification, non-target DNA panels
were created with the remaining six Hypericum species
(Table 2). This meant that six species could be eliminated
for cross-amplification in one reaction. As each species
represented one-sixth of the DNA present in the panel (e.g.
5ng each, totalling 30 ng), the DNA used to check for amp-
lification of the target DNA was diluted to produce the
same final concentration (e.g. 5 ng).
The reactions consisted of Green GoTaqW Flexi Buffer
(Promega, USA) (1×), MgCl2 (2.5 mM), GoTaq
W DNA
Polymerase (Promega, USA) (1.25 U), relevant primers
(0.1 μM each), dNTPs (0.1 μM each) and template DNA
(1 μL of appropriate sample dilution) made up to a final
volume of 25 μL with nuclease-free water in 0.2-mL
Table 2 Construction of non-target DNA panels from initial High-Fidelity PCR amplifications of vouchered DNA
samples
Panel H. androsaemum H. kouytchense H. maculatum H. athoum H. calycinum H. ascyron H. perforatum
Non-and x ✓ ✓ ✓ ✓ ✓ ✓
Non-ath ✓ ✓ ✓ x ✓ ✓ ✓
Non-asc ✓ ✓ ✓ ✓ ✓ x ✓
Non-perf ✓ ✓ ✓ ✓ ✓ ✓ x
Multiplex ✓ ✓ ✓ ✓ ✓ ✓ ✓
The initial PCR products were diluted by 1 × 10-5 (except H. athoum, 1 × 10-4) and equal volumes of each sample were added to the panel mixtures, as indicated
by a tick. The panels are described by the name of the species that is not present, indicated by a cross. These panels were then used to test the species-specific
primers for each target for cross-amplification, allowing six DNA samples to be tested simultaneously. The panel used to test the multiplex reaction contained all
the available samples, and is named Multiplex.
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thermal cycler was used with the following programme:
initial denaturation step of 7 min at 95°C; 30 cycles of 1
min at 95°C, 30 s at 60°C and 1 min at 72°C; and final
extension period of 7 min at 72°C. Combinations requir-
ing further optimisation were run on a gradient of
annealing temperatures from 55°C to 69°C, with all other
parameters as described above. Reactions without tem-
plate DNA were utilised as controls. The PCR products
were electrophoresed in 50-mL 3% (w/v) agarose, 0.5×
TBE gels with 1 μL of SYBRsafe™ (Invitrogen, USA)
DNA stain at 90 V for ~30 min and analysed using an Il-
luminator with a ChemiDoc XRS Camera and Quantity
One software (Bio-Rad, USA).
Commercial samples
The commercial materials were capsules filled with dried,
ground plant material from three companies, which were
labelled as containing the following: Company A, 334 mgFigure 1 ITS amplification products from all seven Hypericum sample
panel composition is described in Table 2. The species-specific products fro
H. athoum, 131 bp; H. perforatum, 222 bp; and H. ascyron, 231 bp), each beSt John’s Wort extract per capsule; Company B, 300 mg of
St John’s Wort pure powdered herb per capsule; and Com-
pany C, 333 mg of St John’s Wort (H. perforatum) standar-
dised herb extract and 114 mg of other plant extracts and
concentrates.
DNA extraction
DNA extraction was carried out utilising a DNeasy Plant
Mini Kit (Qiagen, USA) and a TissueLyser (Qiagen, USA).
Manufacturer’s instructions were followed with the excep-
tion of conducting two disruption steps of 1 min at 30 Hz
after the addition of 400 μL of Buffer AP1 and 4 μL of
RNase A to the sample at the beginning of the procedure.
Dried material (0.02 g) from within the capsules was used
and the resultant DNA samples stored at 2-5°C.
Multiplex PCR
A DNA panel was created that included all seven Hyperi-
cum species available to optimise the multiplex PCRs were included as templates in a multiplex PCR. The multiplex
m all of the four target species are shown (H. androsaemum, 67 bp;
ing automatically identified using the GeneMapper software.
Table 3 Candidate primer pairs for species-specific identification of the target DNAs
Forward primer name Sequence 5′ to 3′ Tm Reverse primer name Sequence 5′ to 3′ Tm Amplicon length (bp)
Hand F 1 2 ACATCGTCGCCCCAAACC 67.0 Hand R 1 2 CCATTATCCGCCCCATCCTC 66.5 65
Hand F 1 3 AAATGTGATACTTGGTGTGAATTGC 64.7 Hand R 1 3 CGAGGTGTTGGGTTTGGG 64.8 135
Hand F 1 4 CACATCGTCGCCCCAAAC 65.6 Hand R 1 4 ACCATTATCCGCCCCATCC 65.9 67
Hand F 1 4 CACATCGTCGCCCCAAAC 65.6 Hand R 1 5 TTATCCGCCCCATCCTCTTC 65.4 63
Hand F 1 5 CGGCTGTCCTCCTGTTCATAAC 67.1 Hand R 1 6 TCACACCAAGTATCACATTTCGCTAC 67.3 98
Hand F 2 1 CGAAATGTGATACTTGGTGTGAATTG 65.1 Hand R 1 3 CGAGGTGTTGGGTTTGGG 64.8 137
Hasc F 1 2 TTCCTTCGGTTCATAACTAAAAC 60.9 Hasc R 1 2 ACCCAATGAACTCGAAAGAG 61.7 225
Hasc F 1 4 GTGGCTTTCCTTCGGTTC 62.5 Hasc R 1 2 ACCCAATGAACTCGAAAGAG 61.7 231
Hasc F 1 3 TTTCCTTCGGTTCATAACTAAAAC 61.5 Hasc R 1 1 GAACTCGAAAGAGGCATTG 60.4 219
Hasc F 1 5 TCCTTCGGTTCATAACTAAAAC 60.2 Hasc R 1 1 GAACTCGAAAGAGGCATTG 60.4 217
Hath F 1 1 CCCCGAAATTCCGATATCTC 61.8 Hath R 1 1 CTTACAACCACCGCTAGTC 61.7 137
Hath F 1 1 CCCCGAAATTCCGATATCTC 61.8 Hath R 1 3 CAACCACCGCTAGTCGTG 64.6 133
Hath F 1 1 CCCCGAAATTCCGATATCTC 61.8 Hath R 1 4 CCGCTAGTCGTGGCTTTG 64.9 127
Hath F 1 3 GTGTCACACATCGTTGCC 63.2 Hath R 1 3 CAACCACCGCTAGTCGTG 64.6 151
Hper F 1 1 TGTAACGCTCCCGGCTGTG 69.0 Hper R 1 1 CCGATTGTCTCTTGCGAGATATC 65.0 273
Hper F 4 1 GGGGCTTCCTTCTGTTCATAAC 65.1 Hper R 4 1 TCTTGCGAGATATCGGGATTTTG 64.9 222
Hper F 1 2 ATAAGAAGTGTAACGCTCCCGGCTGTG 72.5 Hper R 1 1 CCGATTGTCTCTTGCGAGATATC 65.0 281
Hper F 1 3 GAAGTGTAACGCTCCCGGCTGTG 71.9 Hper R 1 1 CCGATTGTCTCTTGCGAGATATC 65.0 277
Hper F 1 4 AGTGTAACGCTCCCGGCTGTG 71.2 Hper R 1 1 CCGATTGTCTCTTGCGAGATATC 65.0 275
The selected pairs are indicated in bold. Candidate selection was based on specificity, and further analysis of theoretical interactions in the multiplex PCR and discrimination of amplicons by capillary electrophoresis
were used to make the final selection.
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Figure 2 Image of gel containing the PCR products from the H.
androsaemum primers (as labelled) and H. androsaemum
template DNA. The product sizes from top to bottom are 137, 98,
63, 67, 135 and 65 bp. The primer pair Hand.F.1.4 and R.1.4 was
selected for the PlantID assay.
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were conducted in 0.2-mL polypropylene tubes using a
Multiplex PCR Kit (Qiagen Inc., USA). The reactions con-
sisted of Multiplex PCR Master Mix (Qiagen Inc., USA)
(1×), primer mix (H. perforatum, 500 nM; H. athoum, 110
nM; H. androsaemum, 80 nM; H. ascyron, 400 nM) (IDT,
USA), template PCR product (0.4 μL at the working con-
centration) and nuclease-free water. The forward primers
were labelled with 6-carboxyfluorescein (FAM). Reactions
without either template PCR product or primers were used
as controls. The PCR cycling parameters were: initial de-
naturation step of 15 min at 95°C; 30 cycles of 30 s at 94°
C, 90 s at 64°C and 60 s at 72°C; and final extension period
of 30 min at 60°C. Genomic multiplex reactions were con-
ducted with a mixture containing equal concentrations of
genomic DNA from H. androsaemum, H. athoum, H. per-
foratum and H. ascyron (Table 1).Capillary electrophoresis
The fluorescently labelled multiplex PCR products were
analysed in an ABI Prism™ 3130 Genetic Analyzer (Applied
Biosystems, USA) using a 30-cm capillary and Performance
Optimised Polymer 4 (Applied Biosystems, USA). The run
module used consisted of a 12-s injection at 1.2 kV, fol-
lowed by electrophoresis at 60°C and 15 kV for 25 min.
Each multiplex PCR product (1 μL) was diluted with 8.5
μL of Hi Di™ Formamide and 0.5 μL of GeneScan™-500
ROX™ size standard (Applied Biosystems, USA) before theHasc.F.1.4
Hper.F.4.1
H
Hath.F.1.
ITS1
18S 5.8S
H
750bp
Figure 3 Representation of the nuclear ribosomal coding region with
annealing positions of the four selected primer pairs are shown.capillary electrophoresis. GeneMapperW ID v3.2 fragment
analysis software (Applied Biosystems, USA) was used.
The candidate primers were introduced to the multi-
plex reaction. This was carried out with the mixture of
all seven Hypericum species nrITS sequences (Table 2),
and the products were separated by capillary electro-
phoresis (Figure 1). The concentration of each primer
pair was optimised to account for the efficiency differ-
ences found when introducing the primers into a multi-
plex reaction. Panels and bins were created in
GeneMapper ID v.3.2 (Applied Biosystems, USA) follow-
ing the instructions in the software, to allow for auto-
matic recognition and labelling of amplicons falling
within ± 0.5 bp of the determined fragment size for each
species of interest.
Results
The nrITS sequences from seven Hypericum species
were aligned and analysed to provide the basis for the
species-specific primer design. PCR primers were
designed for regions where the sequences of the four tar-
get species (H. androsaemum, H. ascyron, H. athoum
and H. perforatum) differed from all the other species.
The sequences of each primer pair were species-specific,
because they matched only one sequence from all the in-
put sequences. A total of 19 primer pairs were designed,
all of which produced amplicons of the expected size
when tested with the target DNA template in conven-
tional PCR: six pairs for H. androsaemum; four pairs for
H. ascyron; four pairs for H. athoum; and five pairs for
H. perforatum (Table 3). The results for the six
H. androsaemum pairs are shown in Figure 2.
The primer pairs were tested for cross-amplification
against a panel of nrITS sequences from closely related
Hypericum species, the non-target panel (Table 2). In
each case, panels were constructed using High-Fidelity
PCR amplifications of the nrITS regions from vouchered
species specimens. Primer pairs that gave a product with
the nrITS of the target DNA, but not with the non-
target DNA panel, were candidates for the multiplex re-
action. Of the candidate primer pairs found for each of
the four species, one primer pair per species was
selected for the multiplex reaction (shown in Figure 3,
highlighted in Table 3). These pairs were chosen basedand.F.1.4
3
ITS2
28S
Hath.R.1.3Hand.R.1.4per.R.4.1
Hasc.R.1.2
the internal transcribed spacers, ITS1 and ITS2. The relative
Figure 4 Multiplex PCR products from a mixture of genomic DNA from the species H. androsaemum, H. athoum, H. perforatum and
H. ascyron amplified with corresponding species-specific PCR primers. Each peak is automatically identified and confirms the presence of
the named DNA.
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indicated a low possibility of interactions between the
candidate primers when all were introduced into a
multiplex system. The candidate primers were also
selected based on the size of the resultant amplicons, be-
cause the products must be sufficiently different in size
to facilitate their separation by capillary electrophoresis.
Consequently, a minimum length difference of 5 bp was
considered.
PCR products were used as the templates for the de-
sign and optimisation of the assay. But genomic DNA is
likely to be the eventual target for the method. The assay
was conducted with mixtures of genomic DNA from
each of the target species to ensure that the assay was
equally efficient for this type of sample (Figure 4), pro-
ducing a higher quality profile of peaks with fewer base-
line anomalies.
The working assay was used to test DNA extracted
from commercial preparations of St. John’s Wort sold in
capsule or tablet form, produced by companies A, B and
C. The three DNA samples were previously confirmed
by conventional PCR of the ITS regions [17]. DNA deg-
radation and/or shearing was observed in the samples
from companies A and B, as the 750-bp ITS region
could not be amplified, while a smaller amplicon (160
bp) within this region was amplified. This may have
arisen because of the age and processed nature of the
plant material. The sample from company C produced
the full 750-bp ITS amplicon.
The multiplex reaction was carried out using DNA
extracted from the three samples. The DNA extracted
from the samples of companies A and B was identifiedas H. perforatum, whereas the DNA from the sample of
company C was not identified as any of the Hypericum
species in the assay (Figure 5). The sample from com-
pany C is labelled as a mixture of plant extracts, and the
amplified DNA may come from another species. How-
ever, H. perforatum was stated as the dominant plant
component, and would have been expected to be the
dominant DNA component.
Discussion
The developed assay, PlantID, can detect four closely
related species (i.e. the number of sequence differences
between species within the nrITS region is minimal)
simultaneously in one reaction within a mixture of seven
species. Variation in the sequences used for the design
confers the possibility for successful species-specific pri-
mer design, which is essential for this assay. The plant
species in genuine cases of misidentification or adulter-
ation may not be this closely related, and are likely to
contain more DNA sequence variation.
During the design process, amplicons were ensured to
be of the shortest possible length, thereby optimising the
technique for use with degraded or fragmented samples
following the miniSTR (Sequence Tagged Repeat) ap-
proach introduced by Butler in 2003 [18]. This enables
the assay to be used with commercial products contain-
ing highly processed plant material. This is of particular
importance when testing tablet forms of herbal medi-
cines, as well as ingested samples collected during post-
mortem [19].
The number of species identified using this technique
could be dramatically increased by altering a few
AB
C
Figure 5 (See legend on next page.)
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Figure 5 Multiplex PCR product profiles from DNA extracted from three different companies products(companies A, B and C, panels
labelled respectively). The results show a positive peak for H. perforatum for companies A and B, but not for company C.
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was used in this study, the system is capable of simultan-
eous detection of five fluorophores in a run. One of
these fluorophores is reserved for the size standard, leav-
ing four options for primer labelling, which can increase
the detection yield by four-fold. In addition, the nrITS
region alone was the basis for this “proof of concept”
assay design. The use of more DNA regions would in-
crease possibilities for unique annealing positions for
primers, thereby increasing detection. The use of mul-
tiple DNA sequence regions for the assay design could
also confer greater reliability. The technique could be
further developed such that each species is identified by
the presence of several peaks, which would greatly re-
duce the possibility of a false-positive result. The opti-
misation of this assay will aim to achieve the optimal
multiplex reaction so that each peak produced is of
equal intensity when the input DNA templates are at the
same concentration. This would then produce a semi-
quantitative assay, with relative peak heights indicating
which DNAs are present at the highest and lowest
concentrations.
The evaluation of polyherbal preparations would bene-
fit from the development of this type of assay, for which
no other techniques can confirm the presence of each
individual species. For example, Ayurvedic preparations,
such as Dashmool, contain many different plant species
that are highly processed, making them impossible to
identify morphologically. Chemical analyses of such a
mixed preparation containing many compounds from
different species produce a highly complex profile. Sub-
stitution of the raw materials in this preparation is com-
mon and has led to the development of a DNA-based
assay that can identify one species that should be in the
preparation (Desmodium gangeticum) and two species
that are often found as adulterants (Desmodium veluti-
num and Desmodium triflorum) [20]. Each of these is
identified by an individual PCR, the product of which is
then analysed by gel electrophoresis. However, the
multiplex PlantID system could potentially identify all
10 different species that should be present in the prepar-
ation, and also test for species that are known to be used
as adulterants, in one reaction.
Conclusion
This technique can detect the presence of an expected
plant material and adulterant materials in one reaction.
The method could be simply applied to other medicinal
plants and their problem adulterants.Abbreviations
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